1. Modelling the tumour microenvironment and employing functional genomics identifies CREBBP as a novel tumour suppressor in triple negative breast cancers. (July 2016) Authors: Peck, B.; Maguire, S.; Morrison, E.; Wai, P.; Natrajan, R. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PPP2R1A missense mutations as a novel biomarker of response to ATR inhibitors in ARID1A mutant ovarian clear cell carcinoma. (October 2022) Authors: Stewart, J.; Baxter, J.; Zatreanu, D.; Brough, R.; Song, F.; Konde, A.; Krastev, D.; Alexander, J.; Natrajan, R.; Banerjee, S.; Stephen, P.; Lord, C. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The anion channel GPR89 is a novel oncogene associated with tumour specific dependency in breast cancer. (October 2022) Authors: Ferro, R.; Carroll, A.; Mendes-Pereira, A.; Reen, V.; Roxanis, I.; Annunziato, S.; Jonkers, J.; Liv, N.; Alexander, J.; Quist, J.; Pardo, M.; Roumeliotis, T.I.; Choudhary, J.S.; Weekes, D.; Marra, P.; Natrajan, R.; Grigoriadis, A.; Haider, S.; Lord, C.J.; Tutt, A.J. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The characterisation of potential fusion genes in breast cancer. (July 2016) Authors: Noor, A. Mohd; Maguire, S.; Watkins, J.; Quist, J.; Mirza, H.; Ougham, K.; Tutt, A.; Gillett, C.; Natrajan, R.; Grigoriadis, A. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗